Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Amyotrophic lateral sclerosis.

Current opinion in neurology·2022
Same author

Association of Serum GFAP with Functional and Neurocognitive Outcome in Sporadic Small Vessel Disease.

Biomedicines·2022
Same author

CSF levels of SNAP-25 are increased early in Creutzfeldt-Jakob and Alzheimer's disease.

Journal of neurology, neurosurgery, and psychiatry·2022
Same author

Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy.

Annals of clinical and translational neurology·2022
Same author

Fast versus slow disease progression in amyotrophic lateral sclerosis-clinical and genetic factors at the edges of the survival spectrum.

Neurobiology of aging·2022
Same author

Cognition in the course of ALS-a meta-analysis.

Amyotrophic lateral sclerosis & frontotemporal degeneration·2022

Related Experiment Video

Updated: Mar 27, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

29.5K

A large-scale multicentre cerebral diffusion tensor imaging study in amyotrophic lateral sclerosis.

Hans-Peter Müller1, Martin R Turner2, Julian Grosskreutz3

  • 1Department of Neurology, University of Ulm, Ulm, Germany.

Journal of Neurology, Neurosurgery, and Psychiatry
|January 10, 2016
PubMed
Summary

Diffusion tensor imaging (DTI) reveals widespread brain connectivity changes in amyotrophic lateral sclerosis (ALS) beyond motor pathways. This multicenter study validates DTI metrics for tracking ALS progression and potential treatments.

More Related Videos

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

9.4K
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

26.0K

Related Experiment Videos

Last Updated: Mar 27, 2026

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases
09:33

Diffusion Tensor Magnetic Resonance Imaging in the Analysis of Neurodegenerative Diseases

Published on: July 28, 2013

29.5K
Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression
07:00

Diffusion Tensor Magnetic Resonance Imaging in Chronic Spinal Cord Compression

Published on: May 7, 2019

9.4K
Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging
12:21

Probing the Brain in Autism Using fMRI and Diffusion Tensor Imaging

Published on: September 12, 2011

26.0K

Area of Science:

  • Neuroimaging
  • Neurology
  • Biomarker Development

Background:

  • Amyotrophic lateral sclerosis (ALS) involves structural connectivity damage extending beyond motor pathways.
  • Diffusion tensor imaging (DTI) can visualize these changes, but requires standardization for biomarker use.
  • Multicenter studies are crucial for validating DTI metrics across diverse MRI scanners and patient cohorts.

Purpose of the Study:

  • To assess structural connectivity in ALS using DTI across a large, multicenter sample.
  • To overcome challenges in processing multiplatform, multicenter DTI data.
  • To establish DTI-based anatomical fingerprint patterns reflecting ALS disease stages.

Main Methods:

  • Retrospective analysis of 442 DTI datasets from 253 ALS patients and 189 controls across eight international sites.
  • Utilized fractional anisotropy (FA) maps and developed correction matrices and algorithms to pool data from varied equipment and protocols.
  • Employed whole-brain-based statistical analysis of corrected FA maps.

Main Results:

  • Confirmed significant alterations in corticospinal tracts, consistent with previous findings.
  • Identified additional white matter tract changes in frontal lobe, brainstem, and hippocampal regions in ALS patients.
  • Observed changes correlated with postmortem neuropathological stages and disease severity (ALS Functional Rating Scale).

Conclusions:

  • Successfully processed and analyzed multiplatform, multicenter DTI data, demonstrating robust findings.
  • Established DTI-based anatomical fingerprint patterns that reflect distinct ALS disease stages.
  • Paved the way for using DTI metrics in natural history studies, prognostic stratification, and multisite clinical trials for ALS.